https://www.selleckchem.com/pr....oducts/bms-927711.ht
The wearable cardioverter/defibrillator (WCD) is recommended to prevent sudden cardiac death (SCD). Guidelines suggest a 90 days' period, but prolongation of WCD wear time until increasing the ejection fraction (≥35%) might be suggested. A cohort of 153 patients with prescribed WCD were divided into two groups A 90 wear days' group (n=112) vs. ≥90 wear days' group (n=41) and followed. In the first group, WCD shock occurred in 3.6% of patients, 47.3% improved in left ventricular ejection fraction (LVEF) after 3 months, and 37.5% h
Like
Comment
Share
